Research Frontiers Stock Forecast, Price & News

Wall Street analysts have given Research Frontiers a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Research Frontiers wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Research Frontiers saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 1,110,000 shares, a decline of 55.1% from the June 15th total of 2,470,000 shares. Based on an average daily trading volume, of 202,000 shares, the days-to-cover ratio is currently 5.5 days. Approximately 4.2% of the shares of the company are sold short.
View Research Frontiers' Short Interest.

Research Frontiers is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for Research Frontiers.

Research Frontiers Incorporated (NASDAQ:REFR) issued its quarterly earnings results on Thursday, May, 6th. The technology company reported ($0.02) EPS for the quarter. The technology company had revenue of $0.21 million for the quarter. Research Frontiers had a negative trailing twelve-month return on equity of 58.92% and a negative net margin of 270.69%.
View Research Frontiers' earnings history.

Research Frontiers' stock was trading at $2.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, REFR shares have decreased by 6.9% and is now trading at $2.55.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Research Frontiers include VirnetX (VHC), Acacia Research (ACTG), Pendrell (PCOA), Quarterhill (QTRHF), Health Discovery (HDVY), Network-1 Technologies (NTIP), Xcel Brands (XELB), Micro Imaging Technology (MMTC), Mills Music Trust (MMTRS), ARC Group (RLLY), ARC Group (ARCK), American Restaurant Partners (ICTPU), Envit Capital Group (ECGP) and Patriot Scientific (PTSC).
View all of REFR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Research Frontiers investors own include MicroVision (MVIS), Energy Transfer (ET), Immunomedics (IMMU), Onconova Therapeutics (ONTX), The Blackstone Group (BX), Elite Pharmaceuticals (ELTP), iBio (IBIO), SandRidge Permian Trust (PER), SeaChange International (SEAC) and Weyerhaeuser (WY).

Research Frontiers trades on the NASDAQ under the ticker symbol "REFR."

Shares of REFR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of REFR stock can currently be purchased for approximately $2.55.

Research Frontiers has a market capitalization of $80.71 million and generates $830,000.00 in revenue each year.

Research Frontiers employs 6 workers across the globe.

The official website for Research Frontiers is www.smartglass.com.

Research Frontiers is headquartered at 240 CROSSWAYS PARK DRIVE, WOODBURY NY, 11797.

Research Frontiers' mailing address is 240 CROSSWAYS PARK DRIVE, WOODBURY NY, 11797. The technology company can be reached via phone at 516-364-1902 or via email at [email protected]